Ridinilazole: A novel therapy for Clostridium difficile infection

Vickers, RJ, Tillotson, G, Goldstein, EJC et al. (3 more authors) (2016) Ridinilazole: A novel therapy for Clostridium difficile infection. International Journal of Antimicrobial Agents, 48 (2). pp. 137-143. ISSN 0924-8579



  • Vickers, RJ
  • Tillotson, G
  • Goldstein, EJC
  • Citron, DM
  • Garey, KW
  • Wilcox, MH
Copyright, Publisher and Additional Information: © 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Ridinilazole; SMT19969; Clostridium difficile infection; Antibacterial therapy; Gut microbiota
  • Accepted: 23 April 2016
  • Published (online): 30 May 2016
  • Published: August 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Oct 2016 11:50
Last Modified: 05 Oct 2017 16:26
Published Version: http://dx.doi.org/10.1016/j.ijantimicag.2016.04.02...
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ijantimicag.2016.04.026

Share / Export